94 results
Page 3 of 5
8-K
EX-99.1
8cz6pa 75vq5050nzqiw
19 May 22
Pulse Biosciences, Inc. Announces Changes to its Rights Offering
8:28am
8-K
EX-99.1
xp085 y8l712el4v
11 May 22
Pulse Biosciences Reports First Quarter 2022 Financial Results
4:21pm
8-K
EX-99.7
2vpck7z 7x5hacj
4 May 22
Other Events
8:20am
8-K
EX-99.1
ygt9oexkrt jxb9rx2
14 Apr 22
Pulse Biosciences, Inc. Announces Rights Offering
4:23pm
8-K
EX-99.1
fqy 9dftltfg7j70cv3
31 Mar 22
Pulse Biosciences Reports Fourth Quarter & Full Year 2021 Financial Results
4:19pm
8-K
EX-99.1
svzhgz1i7w4efr8 56r
15 Feb 22
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
9:26am
8-K
EX-99.1
ljnir59avwlhy15a
8 Feb 22
Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission
8:58am
8-K
EX-99.1
c8kg8p7s423y dsufw72
11 Jan 22
Pulse Biosciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial and Operational Results
9:07am
8-K
EX-99.1
be556sqir
15 Nov 21
Pulse Biosciences Reports Third Quarter 2021 Financial Results
12:00am
8-K
EX-99.1
s1ad01amvsyitg6h
6 Oct 21
Pulse Biosciences Appoints Laureen DeBuono to Its Board of Directors
9:02am
8-K
EX-99.1
5l7wnry5gudl1opa
20 Aug 21
Pulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy Officer
4:11pm
8-K
EX-99.1
gq5 5c8y2fm58b8y7
9 Aug 21
Pulse Biosciences Reports Second Quarter 2021 Financial Results
4:32pm
8-K
EX-99.1
rlx2gb
1 Jul 21
Pulse Biosciences Announces $50 Million Private Placement
8:33am
8-K
EX-99.1
lyy9lr
9 Jun 21
Pulse Biosciences Announces Health Canada Approval for CellFX® System
8:22am
8-K
EX-99.1
hvj10upqm80f qu
10 May 21
Pulse Biosciences Reports First Quarter 2021 Financial Results
4:23pm